CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 540 enrolled
Drug / intervention
galyfilcon A, BC 8.30 +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01244516
NCT01244516N/ACompleted

Multi-Center 2-Week Clinical Evaluation of Three Silicone Hydrogel Contact Lenses

Johnson & Johnson Vision Care, Inc.·interventional·Posted Nov 19, 2010·Updated Jun 19, 2018

In Brief

A clinical study evaluating galyfilcon A, BC 8.30, lotrafilcon B, BC 8.60, and 1 other intervention for Myopia. Completed, enrolled 540 participants across 35 sites.

Detailed Summary

The purpose of this study is to compare the clinical performance of three silicone hydrogel contact lenses over a 2 week period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 19, 2010
Enrollment StartSep 1, 2010
Primary CompletionNov 1, 2010
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.6 years ago

Interventions

galyfilcon A, BC 8.30device

galyfilcon A, BC 8.30 soft contact lens

lotrafilcon B, BC 8.60device

lotrafilcon B, BC 8.60 soft contact lens

comfilcon A, BC 8.60device

comfilcon A, BC 8.60 soft contact lens